Role of Matrix Metalloproteinase-2 in the Development of Cyclophosphamide-Induced Cardiomyopathy
- 24 Downloads
Immunohistochemical assay was employed to determine localization of MMP-2 in cardiomyocytes of WAG rats and changes in MMP-2 expression during modeled cardiomyopathy induced by single intraperitoneal injection of cyclophosphamide (125 mg/kg) alone or in combination with preventive intraperitoneal administration of an equal dose of asparcam-L (potassium-magnesium asparaginate) 30 min prior to the cytostatic. In the myocardium of control and experimental rats, MMP-2 was mostly located in cardiomyocyte nuclei. During the development of cyclophosphamide-induced cardiomyopathy (in 3 days after injection), the index of MMP-2-positive cardiomyocyte nuclei increased by 76%. In contrast to control hearts, MMP-2 was also expressed in the cardiomyocyte sarcoplasm. Preventive injection of asparcam-L moderated the cardiotoxic effect of cyclophosphamide, which manifested in less pronounced increase in the volume density of cardiomyocytes with lytic changes (by 42%) and index of MMP-2+ cardiomyocyte nuclei (by 23%) in comparison with the rats exposed to cyclophosphamide alone.
Key Wordscardiomyopathy cyclophosphamide matrix metalloproteinase-2 potassiummagnesium asparaginate immunohistochemistry
Unable to display preview. Download preview PDF.
- 1.Kamyshnikov VS. Reference Book on Clinical and Chemical Laboratory Diagnostics. Vol. 2. Minsk, 2000. Russian.Google Scholar
- 2.Lushnikova EL, Nikityuk DB, Klinnikova MG, Koldysheva EV, Mzhel’skaya MM. Expression of matrix metalloproteinase-2 in the myocardium in the experimental model of anthracycline cardiomyopathy. Morfologiya. 2016;150(6):29-33. Russian.Google Scholar
- 3.Nepomnyashchikh LM, Lushnikova EL, Bakarev MA, Nikityuk DB, Yuzhik EI, Mzhelskaya MM, Nepomnyashchikh RD, Klinnikova MG, Karpova AA. Immunohistochemical Analysis of MMP-2 Expression in the Myocardium During the Postinfarction Period. Bull. Exp. Biol. Med. 2015;159(4):505-510.CrossRefPubMedGoogle Scholar
- 7.Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S, Karliner JS, Lovett DH. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2007;292(4):H1847-H1860.CrossRefPubMedGoogle Scholar